Anisole

Anisole

SCHEMBL27631024

C#CCC.COc1ccccc1

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA4 P22748 1/20 0.64
LTA4H P09960 3/20 0.54
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CA14 Q9ULX7 1/20 0.43
TRPA1 O75762 1/20 0.43
DRD2 P14416 1/20 0.43
DRD4 P21917 1/20 0.43
DRD3 P35462 1/20 0.43
PYCR1 P32322 1/20 0.43
MAOB P27338 1/20 0.41
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
SIGMAR1 Q99720 1/20 0.40
PBRM1 Q86U86 1/20 0.40
NR1I2 O75469 1/20 0.39
HSD11B1 P28845 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1,4-Dimethoxybenzene SCHEMBL27368038 0.88 CA1 (0.58) CA4LTA4HCA12CA1CA2
Anisole SCHEMBL27935346 0.84 CA4 (0.61) CA4LTA4HCA12CA1CA2
1,3-Dimethoxybenzene SCHEMBL27963601 0.84 MAOB (0.50) CA1CA2CA7CA9MAOB
Anisole SCHEMBL28273340 0.84 CA4 (0.61) CA4LTA4HCA12CA1CA2
Anisole SCHEMBL27562012 0.83 CA4 (0.82) CA4LTA4HCA12CA1CA2
Anisole SCHEMBL27648638 0.82 CA4 (0.64) CA4LTA4HCA12CA1CA2
Anisole SCHEMBL1745082 0.81 CA4 (0.70) CA4LTA4HCA12CA1CA2
Anisole SCHEMBL11151351 0.80 CA4 (0.78) CA4LTA4HCA12CA1CA2
Anisole SCHEMBL28273151 0.80 CA4 (0.78) CA4LTA4HCA12CA1CA2
Anisole SCHEMBL27484333 0.80 CA4 (0.88) CA4LTA4HCA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109748911-A A kind of IDO inhibitor containing triazole, preparation method and its medical usage 中国药科大学 2019-05-14 CN disclosed
CN-108137591-A Based on two pyrrolo- [1,2-b:1 ', 2 '-g] [2,6] benzodiazine -5,11- diketone polymer and compound 巴斯夫欧洲公司 2018-06-08 CN disclosed
CN-102574870-B Luminescent gold (III) compound containing bidentate ligand for organic light-emitting device and preparation method thereof THE UNIVERSITY OF HONG KONG (CN) 2016-05-18 CN disclosed
CN-101365446-B Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery via implantable medical devices RESVERLOGIX CORP 2013-05-22 CN disclosed
CN-101939053-A Soluble guanylate cyclase activators MERCK SHARP & DOHME 2011-01-05 CN disclosed
CN-101365446-A Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery via implantable medical devices RESVERLOGIX CORP (CA) 2009-02-11 CN disclosed
CN-101027051-A Methods for treating hepatitis C PTC THERAPEUTICS INC (US) 2007-08-29 CN disclosed
CN-1914188-A Cationic substituted benzofurans as antimicrobial agents UNIV NORTH CAROLINA (US) 2007-02-14 CN disclosed
CN-1771050-A macrocyclic inhibitors of hepatitis c serine protease ENANTA PHARM INC (US) 2006-05-10 CN disclosed